Traci C. Green, PhD, deputy director of the Injury Prevention Center at BMC, received $1.3 million in grant money to determine when and how naloxone — also called Narcan — should be offered to patients.
“We don’t yet have a good sense of how to do this right. But we really felt that the pharmacy would be a good place for prevention tools,” Dr. Green told the Boston Herald. “Pharmacies have incredible reach in every community.”
The study is funded by the Agency for Healthcare Research and Quality and will be conducted in collaboration with Rhode Island Hospital in Providence, CVS Health, and several local community pharmacies in both Massachusetts and Rhode Island.
More articles on opioids and drug addition:
HHS pledges $100M to combat national drug addiction epidemic
Physicians, patients feel ‘uncomfortable’ discussing chronic pain, opioids: 4 survey findings
Multimodal pain management: How it can improve outcomes & reduce opioid dependence
